Fingerprint
Dive into the research topics of 'Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically